Literature DB >> 17404888

CARD15 genotype-phenotype relationships in a small inflammatory bowel disease population with severe disease affection status.

Nigel P S Crawford1, Daniel W Colliver, M Robert Eichenberger, Alisa A Funke, Valentina Kolodko, Gary A Cobbs, Robert E Petras, Susan Galandiuk.   

Abstract

Inflammatory bowel disease (IBD; MIM# 266600) is subdivided on the basis of clinical findings as either Crohn's disease (CD), ulcerative colitis (UC), or indeterminate colitis (IC). Three previously described mutations within the IBD susceptibility gene CARD15 (R702W, G908R, 1007fs) increase susceptibility to CD with a terminal ileal and/or ileocolonic location and fibrostenosing behavior. We undertook an association study using 477 unrelated IBD patients (248 CD, 172 UC, 57 IC) and 104 population controls to determine whether these previously described associations could be replicated in a small, accurately phenotyped cohort. Case-control and family-based approaches were employed to analyze CARD15 mutant allele and haplotype data. Analyses were initially performed in unstratified IBD cohorts. The R702W mutant allele was associated with CD on case-control analysis (q=0.036, P=.004), and 1007fs with CD on pedigree disequilibrium testing (P=.020). All 3 CARD15 mutations increased susceptibility to a variety of CD subphenotypic manifestations, including early-onset CD in individuals with a family history of IBD, and CD complicated by extraintestinal disease. We also present evidence to suggest that R702W may predispose to a more generalized form of CD. Additionally, we confirm that CARD15 mutations are associated with terminal ileal/ileocolonic, and to a lesser extent, fibrostenosing CD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404888     DOI: 10.1007/s10620-006-9208-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Correcting for a potential bias in the pedigree disequilibrium test.

Authors:  E R Martin; M P Bass; N L Kaplan
Journal:  Am J Hum Genet       Date:  2001-04       Impact factor: 11.025

2.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

3.  False discoveries and models for gene discovery.

Authors:  Edwin J C G van den Oord; Patrick F Sullivan
Journal:  Trends Genet       Date:  2003-10       Impact factor: 11.639

4.  Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'.

Authors:  A B Price
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

5.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

6.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

Review 7.  Genotype-phenotype correlations: how many disorders constitute inflammatory bowel disease?

Authors:  Christoph Gasche; Behrooz Z Alizadeh; A Salvador Peña
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-06       Impact factor: 2.566

8.  NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Warren Strober
Journal:  Nat Immunol       Date:  2004-06-27       Impact factor: 25.606

Review 9.  NODs: intracellular proteins involved in inflammation and apoptosis.

Authors:  Naohiro Inohara; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2003-05       Impact factor: 53.106

10.  NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.

Authors:  Mihai G Netea; Bart Jan Kullberg; Dirk J de Jong; Barbara Franke; Tom Sprong; Ton H J Naber; Joost P H Drenth; Jos W M Van der Meer
Journal:  Eur J Immunol       Date:  2004-07       Impact factor: 5.532

View more
  6 in total

Review 1.  The future of molecular approaches to inflammatory bowel disease.

Authors:  Boyko Kabakchiev; Smita Halder; Mark S Silverberg
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

2.  Perianal Crohn's disease: predictive factors and genotype-phenotype correlations.

Authors:  Ziad Kanaan; Surriya Ahmad; Natalia Bilchuk; Crystal Vahrenhold; Jianmin Pan; Susan Galandiuk
Journal:  Dig Surg       Date:  2012-03-22       Impact factor: 2.588

3.  Abdominal wall component release is a sensible choice for patients requiring complicated closure of abdominal defects.

Authors:  Ziad Kanaan; Nathan Hicks; Clayton Weller; Natalia Bilchuk; Susan Galandiuk; Crystal Vahrenhold; Xiaobin Yuan; Shesh Rai
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

4.  Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease.

Authors:  Oriol Juanola; Alba Moratalla; Ana Gutiérrez; Laura Sempere; Pedro Zapater; Paula Giménez; Isabel Almenta; Gloria Peiró; José M González-Navajas; José F Such; Rubén Francés
Journal:  J Gastroenterol       Date:  2014-12-11       Impact factor: 7.527

5.  A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.

Authors:  R J Rigby; M R Hunt; B P Scull; J G Simmons; K E Speck; M A Helmrath; P K Lund
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

6.  Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population.

Authors:  Ziad M Kanaan; Maurice R Eichenberger; Surriya Ahmad; Clayton Weller; Henry Roberts; Jianmin Pan; Shesh N Rai; Robert Petras; E Brooks Weller; Susan Galandiuk
Journal:  J Negat Results Biomed       Date:  2012-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.